Hypofractionation in COVID-19 radiotherapy: A mix of evidence based medicine and of opportunities.
作者信息
Portaluri M, Barba M C, Musio D, Tramacere F, Pati F, Bambace S
机构信息
Dept Radiation Oncology, "A.Perrino Hospital", Brindisi, Italy.
Dept Radiation Oncology, "Vito Fazzi" Hospital, Lecce, Italy.
出版信息
Radiother Oncol. 2020 Sep;150:191-194. doi: 10.1016/j.radonc.2020.06.036. Epub 2020 Jul 2.
Abstract
摘要
相似文献
1
Hypofractionation in COVID-19 radiotherapy: A mix of evidence based medicine and of opportunities.COVID-19放疗中的大分割：循证医学与机遇的结合。
Radiother Oncol. 2020 Sep;150:191-194. doi: 10.1016/j.radonc.2020.06.036. Epub 2020 Jul 2.
2
Good clinical practice and the use of hypofractionation radiation schedules as weapons to reduce the risk of COVID-19 infections in radiation oncology unit: A mono-institutional experience.良好临床实践及采用大分割放疗方案作为降低放射肿瘤学科室新冠病毒感染风险的手段：单机构经验
J Cancer Res Ther. 2023 Apr-Jun;19(3):644-649. doi: 10.4103/jcrt.jcrt_529_21.
3
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial.超分割与常规分割放疗治疗前列腺癌的比较：HYPO-RT-PC 随机、非劣效、III 期临床试验的 5 年结果。
Lancet. 2019 Aug 3;394(10196):385-395. doi: 10.1016/S0140-6736(19)31131-6. Epub 2019 Jun 18.
4
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial.超分割与常规分割放疗治疗前列腺癌（HYPO-RT-PC）的比较：一项随机、对照、非劣效、3 期临床试验的患者报告的生活质量结局。
Lancet Oncol. 2021 Feb;22(2):235-245. doi: 10.1016/S1470-2045(20)30581-7. Epub 2021 Jan 11.
5
Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial.对于前列腺癌患者的低分割与常规分割放疗（HYPRO）：一项随机非劣效性 3 期试验的急性毒性结果。
Lancet Oncol. 2015 Mar;16(3):274-83. doi: 10.1016/S1470-2045(14)70482-6. Epub 2015 Feb 3.
6
Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority, phase 3 trial.对于前列腺癌患者，采用低分割与常规分割放射治疗（HYPRO）：一项随机、非劣效性、3 期试验的晚期毒性结果。
Lancet Oncol. 2016 Apr;17(4):464-474. doi: 10.1016/S1470-2045(15)00567-7. Epub 2016 Mar 9.
7
Hypofractionated radiotherapy in the real-world setting: An international ESTRO-GIRO survey.真实世界环境中的亚分次放疗：一项 ESTRO-GIRO 国际调查。
Radiother Oncol. 2021 Apr;157:32-39. doi: 10.1016/j.radonc.2021.01.003. Epub 2021 Jan 14.
8
Preoperative ultra-hypofractionation radiotherapy in extremity/trunk wall soft tissue sarcoma - A meta-analysis of prospective studies.肢体/躯干壁软组织肉瘤术前超分割放疗——前瞻性研究的荟萃分析
Cancer Radiother. 2023 Apr;27(2):96-102. doi: 10.1016/j.canrad.2022.07.014. Epub 2022 Aug 23.
9
Hypofractionation in Breast Cancer Radiotherapy Across World Bank Income Groups: Results of an International Survey.乳腺癌放疗中的分段治疗在世界银行收入组中的应用：国际调查结果。
JCO Glob Oncol. 2023 Jan;9:e2200127. doi: 10.1200/GO.22.00127.
10
Can the Adoption of Hypofractionation Guidelines Expand Global Radiotherapy Access? An Analysis for Breast and Prostate Radiotherapy.采用大分割放疗指南能否扩大全球放疗可及性？一项针对乳腺癌和前列腺癌放疗的分析。
JCO Glob Oncol. 2020 Apr;6:667-678. doi: 10.1200/JGO.19.00261.
引用本文的文献
1
Nursing Care for Metastatic Bone Cancer: Trends for the Future.转移性骨癌的护理：未来趋势。
Int J Environ Res Public Health. 2023 Jul 31;20(15):6483. doi: 10.3390/ijerph20156483.
2
Prostate brachytherapy utilization in the COVID-19 era: A cross-sectional study of radiation oncologists in the United States.在 COVID-19 时代前列腺近距离放疗的应用：美国放射肿瘤学家的一项横断面研究。
Brachytherapy. 2023 Jan-Feb;22(1):53-57. doi: 10.1016/j.brachy.2022.08.016. Epub 2022 Sep 21.
3
Impact of the COVID-19 pandemic on Radiation Therapy Practice: A Catalyst for Research.2019年冠状病毒病大流行对放射治疗实践的影响：研究的催化剂
Radiography (Lond). 2022 Oct;28 Suppl 1:S13-S15. doi: 10.1016/j.radi.2022.09.004.
4
Defining Radiation Treatment Interruption Rates During the COVID-19 Pandemic: Findings From an Academic Center in an Underserved Urban Setting.定义 COVID-19 大流行期间的放射治疗中断率：来自服务不足的城市环境中的学术中心的发现。
Int J Radiat Oncol Biol Phys. 2023 Jun 1;116(2):379-393. doi: 10.1016/j.ijrobp.2022.09.073. Epub 2022 Sep 30.
5
Trends in Radiation Oncology Treatment Fractionation at a Single Academic Center, 2010 to 2020.2010年至2020年，某单一学术中心放射肿瘤学治疗分割的趋势
Adv Radiat Oncol. 2022 Jul 22;7(6):101032. doi: 10.1016/j.adro.2022.101032. eCollection 2022 Nov-Dec.
6
Covid-19 and radiotherapy: a systematic review after 2 years of pandemic.新冠疫情与放射治疗：大流行两年后的系统评价
Clin Transl Imaging. 2022;10(6):611-630. doi: 10.1007/s40336-022-00513-9. Epub 2022 Jul 23.
7
Impact of the First Wave of COVID-19 Pandemic on Radiotherapy Practice at Tata Memorial Centre, Mumbai: A Longitudinal Cohort Study.COVID-19 大流行第一波对孟买塔塔纪念中心放射治疗实践的影响：一项纵向队列研究。
JCO Glob Oncol. 2022 Jul;8:e2100365. doi: 10.1200/GO.21.00365.
8
Elimination of cervical cancer as a public health problem-how shorter brachytherapy could make a difference during COVID-19.消除宫颈癌这一公共卫生问题——在新冠疫情期间，缩短近距离放射治疗如何发挥作用。
Ecancermedicalscience. 2022 Feb 7;16:1352. doi: 10.3332/ecancer.2022.1352. eCollection 2022.
9
Longitudinal in-vivo quantification of tumour microvascular heterogeneity by optical coherence angiography in pre-clinical radiation therapy.光学相干层析血管造影术在临床前放射治疗中对肿瘤微血管异质性的纵向体内定量分析。
Sci Rep. 2022 Apr 12;12(1):6140. doi: 10.1038/s41598-022-09625-8.
10
Novel coronavirus mitigation measures implemented by radiotherapy centres in low and middle-income countries: a systematic review.低收入和中等收入国家放疗中心实施的新型冠状病毒缓解措施：一项系统综述
Rep Pract Oncol Radiother. 2021 Apr 14;26(2):303-315. doi: 10.5603/RPOR.a2021.0032. eCollection 2021.
本文引用的文献
1
Staff and Patient Protection in Radiation Oncology Departments During Coronavirus Disease 2019 (COVID-19) Pandemic.2019年冠状病毒病（COVID-19）大流行期间放射肿瘤学部门的工作人员和患者保护
Adv Radiat Oncol. 2020 May 19;5(4):628-630. doi: 10.1016/j.adro.2020.04.030. eCollection 2020 Jul-Aug.
2
Palliative Radiation Therapy for Oncologic Emergencies in the Setting of COVID-19: Approaches to Balancing Risks and Benefits.2019冠状病毒病背景下肿瘤急症的姑息性放射治疗：权衡风险与获益的方法
Adv Radiat Oncol. 2020 Apr 8;5(4):589-594. doi: 10.1016/j.adro.2020.04.001. eCollection 2020 Jul-Aug.
3
Recommendations for the use of radiation therapy in managing patients with gastrointestinal malignancies in the era of COVID-19.在 COVID-19 时代管理胃肠道恶性肿瘤患者中放射治疗的应用建议。
Radiother Oncol. 2020 Jul;148:194-200. doi: 10.1016/j.radonc.2020.04.010. Epub 2020 Apr 13.
4
Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement.COVID-19 大流行期间肺癌放疗的实践建议：ESTRO-ASTRO 共识声明。
Radiother Oncol. 2020 May;146:223-229. doi: 10.1016/j.radonc.2020.04.001. Epub 2020 Apr 6.
5
International expert consensus statement regarding radiotherapy treatment options for rectal cancer during the COVID 19 pandemic.关于2019年冠状病毒病大流行期间直肠癌放射治疗选择的国际专家共识声明。
Radiother Oncol. 2020 Jul;148:213-215. doi: 10.1016/j.radonc.2020.03.039. Epub 2020 Apr 2.
6
Cancer and COVID-19 - potentially deleterious effects of delaying radiotherapy.癌症和 COVID-19 - 延迟放疗的潜在有害影响。
Nat Rev Clin Oncol. 2020 Jun;17(6):332-334. doi: 10.1038/s41571-020-0375-1.
7
Management of Locally Advanced Rectal Cancer During The COVID-19 Pandemic: A Necessary Paradigm Change at Memorial Sloan Kettering Cancer Center.新冠疫情期间局部晚期直肠癌的管理：纪念斯隆凯特琳癌症中心必要的范式转变
Adv Radiat Oncol. 2020 Apr 22;5(4):687-689. doi: 10.1016/j.adro.2020.04.011. eCollection 2020 Jul-Aug.
8
Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus Statement.COVID-19 大流行期间适应风险的头颈部癌症放射治疗的实践建议：ASTRO- ESTRO 共识声明。
Int J Radiat Oncol Biol Phys. 2020 Jul 15;107(4):618-627. doi: 10.1016/j.ijrobp.2020.04.016. Epub 2020 Apr 14.
9
Southern Italy: How the Availability of Radiation Therapy, Patient Outcomes, and Risk to Health Care Providers Have Changed During the Coronavirus Disease 2019 Pandemic.意大利南部：2019年冠状病毒病大流行期间放射治疗的可及性、患者预后及医护人员面临的风险如何变化
Adv Radiat Oncol. 2020 Apr 9;5(4):597-600. doi: 10.1016/j.adro.2020.03.016. eCollection 2020 Jul-Aug.
10
Breast Radiation Therapy Under COVID-19 Pandemic Resource Constraints-Approaches to Defer or Shorten Treatment From a Comprehensive Cancer Center in the United States.新冠疫情资源受限情况下的乳腺癌放射治疗——美国一家综合癌症中心延迟或缩短治疗的方法
Adv Radiat Oncol. 2020 Apr 1;5(4):582-588. doi: 10.1016/j.adro.2020.03.013. eCollection 2020 Jul-Aug.
Zotero 插件